We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Radius Health

News List

Radius Health Announces Acquisition of Orphan Disease Program americanpharmaceuticalreview
January 14, 2021
Radius Health announced a definitive agreement to acquire the global development and commercialization rights to Benuvia Therapeutics (Benuvia) synthetic cannabidiol oral solution (RAD011).
Radius Health Announces Commercial Agreement with Paladin Labs for Abaloparatide in Canada americanpharmaceuticalreview
January 13, 2021
Radius Health has entered into definitive agreements with Endo Ventures Limited, a subsidiary of Endo International, to register, commercialize, and distribute abaloparatide on an exclusive basis in Canada.
Radius Health & Menarini Group Provide Elacestrant Update prnasia
September 27, 2020
Radius Health, Inc. and the Menarini Group announced an update on the elacestrant Phase 3 EMERALD trial.